Arbutus Biopharma (ABUS) Operating Margin Growth (1y) (2014 - 2026)
Arbutus Biopharma (ABUS) Operating Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | 155,116.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 155,116.00 |
| Dec 31, 2025 | 38,187.00 |
| Sep 30, 2025 | -3,567.00 |
| Jun 30, 2025 | 126,432.00 |
| Mar 31, 2025 | -19,296.00 |
| Dec 31, 2024 | 8,203.00 |
| Sep 30, 2024 | -113,838.00 |
| Jun 30, 2024 | -85,517.00 |
| Mar 31, 2024 | -100,350.00 |
| Dec 31, 2023 | -60,595.00 |
| Sep 30, 2023 | -16,357.00 |
| Jun 30, 2023 | -29,622.00 |
| Mar 31, 2023 | -17,317.00 |
| Dec 31, 2022 | 28,738.00 |
| Sep 30, 2022 | 25,189.00 |
| Jun 30, 2022 | 70,136.00 |
| Mar 31, 2022 | 65,466.00 |
| Dec 31, 2021 | 3,453.00 |
| Sep 30, 2021 | 44,801.00 |
| Jun 30, 2021 | 6,754.00 |